We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
-$16.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
4.12%
Holding
2,179
New
583
Increased
522
Reduced
502
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 16.3%
2 Technology 15.76%
3 Financials 13.46%
4 Industrials 12.71%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UI icon
2101
Ubiquiti
UI
$34.3B
-3,448
Closed -$2.28M
UMH
2102
UMH Properties
UMH
$1.36B
-151,471
Closed -$2.25M
UNP icon
2103
Union Pacific
UNP
$174B
-1,353
Closed -$320K
UPWK icon
2104
Upwork
UPWK
$1.19B
-68,042
Closed -$1.26M
UPXI icon
2105
Upexi
UPXI
$62.5M
-11,387
Closed -$66K
URGN icon
2106
UroGen Pharma
URGN
$2.29B
-48,964
Closed -$977K
USAC icon
2107
USA Compression Partners
USAC
$3.74B
-10,980
Closed -$264K
USFD icon
2108
US Foods
USFD
$24B
-3,137
Closed -$240K
USLM icon
2109
United States Lime & Minerals
USLM
$3.44B
-1,645
Closed -$216K
UVV icon
2110
Universal Corp
UVV
$1.27B
-5,518
Closed -$308K
VATE icon
2111
INNOVATE Corp
VATE
$165M
-15,821
Closed -$77K
VCEL icon
2112
Vericel Corp
VCEL
$2.31B
-64,387
Closed -$2.03M
VEON icon
2113
VEON
VEON
$3.95B
-16,459
Closed -$896K
VFC icon
2114
VF Corp
VFC
$5.89B
-74,159
Closed -$1.07M
VHT icon
2115
Vanguard Health Care ETF
VHT
$18.6B
-1,820
Closed -$472K
VLN icon
2116
Valens Semiconductor
VLN
$188M
-44,499
Closed -$80K
VLO icon
2117
Valero Energy
VLO
$85.9B
-3,209
Closed -$546K
VLTO icon
2118
Veralto
VLTO
$24B
-3,127
Closed -$333K
VMEO
2119
DELISTED
Vimeo
VMEO
-200,889
Closed -$1.56M
VNO icon
2120
Vornado Realty Trust
VNO
$7.38B
-24,830
Closed -$1.01M
GGRP
2121
Glimpse Group
GGRP
$18.7M
-26,683
Closed -$44K
VRNA
2122
DELISTED
Verona Pharma
VRNA
-11,198
Closed -$1.2M
VRSK icon
2123
Verisk Analytics
VRSK
$25B
-6,680
Closed -$1.68M
VRTX icon
2124
Vertex Pharmaceuticals
VRTX
$126B
-569
Closed -$223K
VTGN icon
2125
VistaGen Therapeutics
VTGN
$12.8M
-31,486
Closed -$112K

Similar funds

GSA Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, GSA Capital Partners held 2,179 positions worth $1.16B, down 3.2% from $1.2B the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

GSA Capital Partners's Q4 2025 filing shows 583 new, 522 increased, 502 reduced and 562 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M. The largest sale was Nuvation Bio, an estimated $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GSA Capital Partners's largest Q4 2025 buy was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M.
  • GSA Capital Partners added most to Remitly in Q4 2025, an estimated $4.91M increase.
  • GSA Capital Partners's biggest Q4 2025 reduction was Nuvation Bio, cutting an estimated $6.32M.
  • GSA Capital Partners fully exited Jefferies Financial Group in Q4 2025, selling an estimated $3.77M.
  • GSA Capital Partners's ten largest holdings make up 4.1% of its $1.16B portfolio in Q4 2025.
  • GSA Capital Partners opened 583 new positions and closed 562 in Q4 2025.
  • GSA Capital Partners's portfolio value fell 3.2% quarter-over-quarter to $1.16B.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.